Abstract
Our recent study demonstrated that an amyloid-β binding molecule, BTA-EG4, increases dendritic spine number via Ras-mediated signaling. To potentially optimize the potency of the BTA compounds, we synthesized and evaluated an amyloid-β binding analog of BTA-EG4 with increased solubility in aqueous solution, BTA-EG6. We initially examined the effects of BTA-EG6 on dendritic spine formation and found that BTA-EG6-treated primary hippocampal neurons had significantly increased dendritic spine number compared to control treatment. In addition, BTA-EG6 significantly increased the surface level of AMPA receptors. Upon investigation into the molecular mechanism by which BTA-EG6 promotes dendritic spine formation, we found that BTA-EG6 may exert its effects on spinogenesis via RasGRF1-ERK signaling, with potential involvement of other spinogenesis-related proteins such as Cdc42 and CDK5. Taken together, our data suggest that BTA-EG6 boosts spine and synapse number, which may have a beneficial effect of enhancing neuronal and synaptic function in the normal healthy brain.
Original language | English (US) |
---|---|
Pages (from-to) | 284-295 |
Number of pages | 12 |
Journal | Biochimica et Biophysica Acta - Molecular Basis of Disease |
Volume | 1862 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2016 |
Bibliographical note
Publisher Copyright:© 2015 Elsevier B.V.
Keywords
- BTA-EG6
- Dendritic spine
- Rap signaling
- Ras signaling